Back to discover
Drug

Glycosphingolipids

Research stage
Emerging research
RxNorm4959
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Glycosphingolipids
RxNorm CUI
4959

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Comparison of the Gut Microbiota of Centenarians in Longevity Villages of South Korea with Those of Other Age Groups.

Journal of microbiology and biotechnology · 2019 · 109 cites
Major research themes2
Gastrointestinal Microbiome1Longevity1
Journals, researchers & institutions
Top journals
  • Journal of microbiology and biotechnology1
Leading researchers
  • Bae JS1
  • Choi CW1
  • Chun J1
  • Chung JH1
  • Han M1
  • Jin SP1
  • Kim BS1
  • Seo EY1
Leading institutions
free-text, unnormalised
  • Hallym University1
  • Institute on Aging1
  • Laboratory of Cutaneous Aging Research1
  • Multidisciplinary Genome Institute1
  • School of Biological Sciences and Inst. of Molecular Biology and Genetics1
  • Seoul National University College of Medicine1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Phosphatidylinositols

Frequently co-studied with Glycosphingolipids in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature